Business Context and Reporting Period
Company: Fresenius Medical Care AG & Co. KGaA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Second Quarter 2006 (Results announced August 3, 2006)
Context: This filing serves as a cover document to furnish an Investor News Release (Exhibit 99.1) containing the Company's second quarter 2006 earnings results.
Key Financial Metrics
The provided text is a cover letter and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing explicitly states that the detailed financial results, including both GAAP and non-GAAP measures, are contained in the attached Investor News Release (Exhibit 99.1).
Non-GAAP Measures Disclosed: The filing notes the use of the following non-GAAP measures in the attached release:
- EBITDA (Operating income excluding depreciation, amortization, and minority interests)
- Operating income excluding one-time costs
- Free cash flow
- Dialysis products external sales
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the attached Exhibit 99.1 for comparative analysis.
Guidance, Outlook, and Risks
Management Commentary: Management states that the non-GAAP measures are provided to enhance the user's understanding of current financial performance and future prospects. They emphasize that these measures provide consistency and comparability with prior periods.
Regulatory Note: The filing includes a standard disclaimer that the attached Investor News Release shall not be deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section.
Risks and Contingencies: No specific risks or contingencies are detailed in this cover document.
Investor Verification Checklist
- Verify the specific revenue and profit figures in the attached Exhibit 99.1 (Investor News Release).
- Review the reconciliation of non-GAAP measures (EBITDA, Free Cash Flow) to GAAP measures as required by Regulation G.
- Confirm the impact of one-time costs on operating income as detailed in the full earnings release.
- Check for any forward-looking guidance or outlook statements contained within Exhibit 99.1.